Provided by Tiger Trade Technology Pte. Ltd.

Mind Medicine (MindMed) Inc.

15.02
0.0000
Volume:- -
Turnover:30.63M
Market Cap:1.48B
PE:-7.60
High:15.02
Open:15.02
Low:15.02
Close:15.02
52wk High:15.29
52wk Low:4.70
Shares:98.51M
Float Shares:91.33M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9758
EPS(LYR):-1.5424
ROE:-85.59%
ROA:-33.95%
PB:11.33
PE(LYR):-9.74

Loading ...

MindMed Announces Inducement Grants for New Employees with Options to Purchase 182,800 Shares

Reuters
·
Sep 23, 2025

Psychedelic: Exclusive talk with biopharma company MindMed

TIPRANKS
·
Sep 18, 2025

MindMed Announces Inducement Grants for New Employees with Options Vesting Over Four Years

Reuters
·
Sep 09, 2025

MindMed Unveils Strategic Focus on GAD and MDD with Late-Stage Pipeline and Innovation in Brain Health

Reuters
·
Sep 05, 2025

MindMed Announces Positive Results from Phase 2b Trial of MM120 for Treating Generalized Anxiety Disorder, Published in JAMA

Reuters
·
Sep 04, 2025

Journal of the American Medical Association (Jama) Publishes Results From First-Ever Randomized, Placebo-Controlled Clinical Trial Assessing the Dose-Dependent Efficacy of Mm120 (Lysergide D-Tartrate, Lsd) in Generalized Anxiety Disorder (Gad)

THOMSON REUTERS
·
Sep 04, 2025

Optimi Health Corp. Secures Regulatory Approval for Launch of Psilocybin Capsules in Australia for Treatment-Resistant Depression

Reuters
·
Sep 03, 2025

Mind Medicine (MindMed) Inc. to Participate in Cantor Global Healthcare Conference 2025

Reuters
·
Aug 28, 2025

MindMed Announces New Employee Compensation Plan with Inducement Grants and Performance Share Units

Reuters
·
Aug 12, 2025

MindMed Q2 2025 Earnings Call Summary and Q&A Highlights: Advancing Pivotal Trials and Strategic Growth

Earnings Call
·
Aug 11, 2025

Stock Track | Mind Medicine (MindMed) Soars 6.87% After Oppenheimer's Bullish $25 Price Target

Stock Track
·
Aug 05, 2025

Stock Track | Mind Medicine (MindMed) Soars 6.61% Pre-market on Oppenheimer's Outperform Rating and $25 Price Target

Stock Track
·
Aug 04, 2025

Mind Medicine MindMed Price Target Announced at $25.00/Share by Oppenheimer

Dow Jones
·
Aug 04, 2025

Oppenheimer Sets Rating on Mind Medicine (MindMed) at Outperform With $25 Price Target

MT Newswires Live
·
Aug 04, 2025

Mind Medicine (MindMed) Inc. Unveils New Corporate Presentation Focused on Transformational Innovation for Brain Health and Late-Stage Pipeline Advancements

Reuters
·
Aug 01, 2025

Mind Medicine (MindMed) Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 01, 2025

Mind Medicine Q2 EPS $(0.50) Misses $(0.37) Estimate

Benzinga
·
Aug 01, 2025

BRIEF-MindMed Q2 Net Income USD -42.744 Million

Reuters
·
Aug 01, 2025

MindMed Reports Q2 2025 Financial Results and Business Updates

THOMSON REUTERS
·
Aug 01, 2025

MindMed Q2 EPS USD -0.5

THOMSON REUTERS
·
Aug 01, 2025